The booster dose should be given at least six months after the second dose is given, and it will be approved for those who are highly susceptible to severe Covit-19 and those who are at work who are at high risk of contracting the disease.
Now the administration of the third dose will be voted on by the Advisory Board of the Centers for Disease Control and Prevention (CDC), which is expected to address Thursday.
President Joe Biden announced in August that he would be introducing a booster dose for 16-year-olds and older. The FDA voted in favor of the idea on Friday, but a panel of experts spoke out against giving the third dose to the general public.
Experts say there is insufficient evidence to support booster vaccines for everyone 16 years of age and older who received the second dose at least six months ago.
During several hours of discussions, experts expressed dissatisfaction with the fact that, in their opinion, there was insufficient data on the safety of the overdose and Pfizer relied on data from Israel, which, in their opinion, would not be sufficient for the situation in the United States.
“Twitter’s irretrievable researcher. An amateur social media lawyer. Award-winning music expert. Became an addict. Easily lethargic.”